Fertin Pharma acquires two companies and bets on cannabis: "It has a great future"
Danish company Fertin Pharma plans to start production of cannabis chewing gum and enters the recently liberalized Canadian cannabis market by acquiring two other firms.
Fertin Pharma expands focus and establishes a new business with one of the most debated drugs of our time: cannabis.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
